We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Published Online:https://doi.org/10.2217/fon-2018-0809c1

The Research article by Thomas Ottoboni, Michael Lauw, Mary Rose Keller, Matt Cravets, Kimberly Manhard, Neil Clendeninn & Barry Quart, ‘HTX-019 via 2-min injection or 30-min infusion in healthy subjects’, which appeared in the March 2019 issue of Future Oncology 15(8), 865–874 (2019), was published with mistake in Table 2. The value for Cmax for the 2-minute injection was listed as ‘13.935’ but has now been changed to ‘13,935’.

The authors and editors of Future Oncology would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.